A family of institutions
working together on the Can Ruti Campus
 

News

15/07/2024 - Research

A new biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

A study led by researchers from the Germans Trias i Pujol Research Institute (IGTP) and Institut Català d’Oncologia (ICO) analysed peripheral blood samples from patients with metastatic colorectal cancer and identified a potential biomarker indicating the effectiveness of oxaliplatin-based treatment. The research has been published in the journal Biomedicine & Pharmacotherapy.

Events

IGTP IN NUMBERS

  • 1115

    Contracted and seconded research staff

  • 332

    Active projects

  • 1077

    Publications

  • 698

    Active clinical trials

  • 39

    Patent families

  • 24

    License agreements

  • 8

    Active spin-offs

The IGTP is an accredited centre of excellence by the Instituto de Salud Carlos III (Spanish Government)

Instituto de Salud Carlos III


The IGTP is a member of


Governance


With the support of


Accreditation